PACS vs PSA · P/E 23, rev $5.29B vs rev $1.23B
PACS Group, Inc. (PACS) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
PACS Group, Inc. (PACS) is a medical care facilities company listed on NYSE.
PSA (PSA) common stock.
Latest reported PACS revenue for 2025-12-31 was $5.29B. Net income was $191.5M. Revenue was up 29.3% from 2024-12-31 to 2025-12-31. PACS currently screens at market cap $5.58B and trailing P/E 22.7.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
PACS currently screens at market cap $5.58B and trailing P/E 22.7. PSA currently screens at market cap $0.
Not investment advice. Open the PACS and PSA stock pages for the full models.
Not investment advice.